Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis-Reference-Cited by-同舟云学术

Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis

Published:2019-06-13 Issue:6 Volume:15 Page:e1007117
ISSN:1553-7358
Container-title:PLOS Computational Biology
language:en
Short-container-title:PLoS Comput Biol

Author:

Verscheijden Laurens F. M.^ORCID,Koenderink Jan B.,de Wildt Saskia N.^ORCID,Russel Frans G. M.^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Computational Theory and Mathematics,Cellular and Molecular Neuroscience,Genetics,Molecular Biology,Ecology,Modelling and Simulation,Ecology, Evolution, Behavior and Systematics

Reference60 articles.

1. The problems in scaling adult drug doses to children;TN Johnson;Arch Dis Child,2008

2. Pediatric Dose Selection and Utility of PBPK in Determining Dose;IE Templeton;AAPS J,2018

3. Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model Construction;J Lu;PLoS Comput Biol,2016

4. Recent Advances in Development and Application of Physiologically-Based Pharmacokinetic (PBPK) Models: a Transition from Academic Curiosity to Regulatory Acceptance;M. Jamei;Curr Pharmacol Rep,2016

5. The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates;A Kim;Invest New Drugs,2012

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reliability of in vitro data for the mechanistic prediction of brain extracellular fluid pharmacokinetics of P-glycoprotein substrates in vivo; are we scaling correctly?;2024-08-14

2. Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for Clinicians;Pediatric Drugs;2024-05-16

3. Predictions of Bedaquiline Central Nervous System Exposure in Patients with Tuberculosis Meningitis Using Physiologically based Pharmacokinetic Modeling;Clinical Pharmacokinetics;2024-03-26

4. Interspecies Brain PBPK Modeling Platform to Predict Passive Transport through the Blood–Brain Barrier and Assess Target Site Disposition;Pharmaceutics;2024-02-04

5. Quantification of meropenem in serum and cerebrospinal fluid in children with bacterial meningitis with augmented renal clearance by UPLC–MS/MS;Heliyon;2024-02